On October 1, 2023, Kiromic Biopharma, Inc. entered into an executive employment agreement with Brian Hungerford pursuant to which Mr. Hungerford will be employed by the Company as Chief Financial Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +5.07% | +20.33% | +233.33% |
10/05 | Kiromic BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01/05 | Kiromic BioPharma, Inc. announced that it has received $2 million in funding | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+233.33% | 3.56M | |
+7.69% | 113B | |
+11.06% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-6.04% | 17.24B | |
+6.89% | 14.29B | |
+35.89% | 12.52B |
- Stock Market
- Equities
- KRBP Stock
- News Kiromic BioPharma, Inc.
- Kiromic Biopharma, Inc. Appoints Brian Hungerford as Chief Financial Officer